Aytu Biopharma Ratios (2010-2026) | AYTU

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	48.12%	56.88%	53.18%	52.42%	54.07%	65.20%	65.81%	56.06%	60.41%	73.18%	77.89%	73.88%	75.73%	72.31%	66.49%	69.40%	67.75%	66.14%	63.46%	61.23%
EBT Margin (Quarter)	-79.80%	-127.68%	-49.95%	-220.22%	-58.62%	-2.53%	-25.47%	-31.67%	-7.99%	-41.94%	7.46%	-12.60%	-17.39%	9.04%	2.35%	20.69%	-128.46%	14.15%	-69.79%	-45.19%
EBIT Margin (Quarter)	-102.51%	-126.50%	-48.84%	-220.76%	254.32%	-6.54%	-26.13%	-37.65%	44.43%	-4.87%	16.78%	-11.39%	-15.58%	-5.61%	-10.45%	13.12%	-17.79%	-10.83%	-12.99%	-32.75%
EBITDA Margin (Quarter)	-102.51%	-126.50%	-48.84%	-220.76%	254.32%	-6.54%	-26.13%	-37.65%	44.43%	-4.87%	16.78%	-11.39%	-15.58%	-5.61%	-10.45%	13.12%	-17.79%	-10.83%	-12.99%	-32.75%
Operating Margin (Quarter)	-102.51%	-126.50%	-48.84%	-220.76%	254.32%	-6.54%	-26.13%	-37.65%	44.43%	-4.87%	16.78%	-11.39%	-15.58%	-5.61%	-10.45%	13.12%	-17.79%	-10.83%	-12.99%	-32.75%
Net Margin (Quarter)	-79.80%	-127.19%	-49.94%	-220.22%	-58.62%	-2.53%	-25.47%	-31.67%	-8.40%	-3.63%	-4.48%	-4.27%	-8.49%	2.30%	0.76%	0.29%	0.41%
FCF Margin (Quarter)	28.72%	-17.31%	-38.15%	-37.67%	-25.85%	-32.91%	-9.51%	-12.73%	30.47%	-1.18%	-0.72%	-1.81%	-7.65%	-8.00%	17.87%	-35.36%	18.41%	-4.45%	24.12%	-33.70%
Efficiency
Inventory Average (Quarter)		16.33M	16.44M	15.22M	12.37M	11.86M	12.91M	13.29M	12.82M	12.48M	12.98M	13.10M	12.67M	11.94M	11.41M	11.07M	11.25M	10.77M	9.38M	8.06M
Assets Average (Quarter)		246.70M	225.78M	196.32M	153.22M	143.81M	145.72M	144.33M	141.84M	134.68M	132.07M	130.06M	123.48M	116.96M	116.03M	120.21M	124.19M	124.58M	123.49M	116.84M
Equity Average (Quarter)		124.53M	108.52M	83.34M	52.73M	46.33M	47.08M	43.36M	40.13M	35.76M	32.51M	31.82M	29.25M	28.77M	30.30M	32.83M	26.93M	21.07M	18.69M	24.67M
Invested Capital (Quarter)	153.85M	127.76M	121.77M	76.99M	59.31M	63.35M	60.82M	55.91M	40.92M	47.17M	33.88M	32.36M	29.57M	31.68M	32.62M	36.76M	20.82M	38.04M	16.06M	45.55M
Asset Utilization Ratio (Quarter)		0.30	0.37	0.47	0.63	0.71	0.72	0.72	0.76	0.72	0.68	0.63	0.53	0.55	0.53	0.55	0.53	0.51	0.51	0.48
Leverage & Solvency
Interest Coverage Ratio (Quarter)										-0.68	2.48	-1.27	-1.81	-0.94	-1.57	2.69	-3.69	-2.91	-3.52	-9.32
Debt to Equity (Quarter)	0.06	0.04	0.01	0.29	0.41	0.30	0.32	0.53	0.41	0.46	0.49	0.05	0.46	0.41	0.38	0.33	0.67	1.09	0.83	0.57
Debt Ratio (Quarter)	0.03	0.02	0.01	0.10	0.13	0.10	0.10	0.15	0.12	0.11	0.12	0.01	0.11	0.11	0.10	0.09	0.10	0.20	0.10	0.18
Equity Ratio (Quarter)	0.52	0.49	0.47	0.36	0.32	0.32	0.32	0.28	0.29	0.24	0.25	0.24	0.23	0.26	0.26	0.28	0.15	0.19	0.12	0.31
Times Interest Earned (Quarter)										-0.68	2.48	-1.27	-1.81	-0.94	-1.57	2.69	-3.69	-2.91	-3.52	-9.32
Valuation
Enterprise Value (Quarter)	-50.15M	-40.56M	-35.28M	-27.61M	-19.36M	-23.81M	-19.50M	-19.18M	-22.98M	-19.96M	-19.53M	-19.76M	-20.01M	-20.11M	-20.40M	-18.17M	-30.95M	-32.63M	-30.02M	-26.71M
Return Ratios
Return on Sales (Quarter)	-0.01%	-0.01%	0.00%	-0.02%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)		-40.96%	-54.82%	-100.45%	-25.46%	4.65%	9.81%	89.24%	-4.92%	-3.81%	10.86%	30.92%	-2.60%	-2.97%	-12.49%	-5.00%	-4.74%	-5.92%	-6.47%	-17.99%
Return on Invested Capital (Quarter)		0.00%	-0.01%	-0.01%	0.00%		0.00%		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)		0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)		0.00%	-0.01%	-0.01%	-0.02%	-0.02%	-0.02%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Aytu Biopharma Ratios (2010-2026) | AYTU

Create an account

Sign In

Reset Password